Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches

By D. Kellar, S. Craft. Lancet Neurology, 2020

638 citations recorded by the source corpus.

Insulin is a peptide secreted by the pancreas and plays an important role in the regulation of glucose metabolism in peripheral tissues. Although the role of insulin in the periphery is well understood, less is known about its multifactorial role in the brain. However, emerging evidence from human and animal studies indicate that insulin influences cerebral bioenergetics, enhances synaptic viability and dendritic spine formation, and increases turnover of neurotransmitters, such as dopamine. Insulin also has a role in proteostasis, influencing clearance of the amyloid β peptide and phosphorylation of tau, which are hallmarks of Alzheimer’s disease. Insulin also modulates vascular function through effects on vasoreactivity, lipid metabolism, and inflammation. Through these multiple pathways, insulin dysregulation could contribute to neurodegeneration. Thus, new approaches to restore cerebral insulin function that could offer therapeutic benefit to adults with Alzheimer’s disease, vascular cognitive impairment, or related disorders are being investigated.

Subfields: Endocrine and Autonomic Systems, Physiology

View Paper: https://www.semanticscholar.org/paper/bdd385e9a802b009e791b109fd900e0cc4acfb0c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Jiaxing Wang
  2. Yilin Xia
  3. Lei Chen
  4. Jiaxian Zhang
  5. Yinglu Zhang
  6. Jifa Zhang

Citations in the corpus